Physician profile
John Moon
NPI 1417912833
$14,623.37
in general payments reported to CMS, 2019-2025
65 companies · $2,109 in 2025
The $2,109 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,951 · 2020: $667 · 2021: $2,544 · 2022: $2,105 · 2023: $2,057 · 2024: $2,191 · 2025: $2,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,211 · Travel and Lodging: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,210.69 |
| Travel and Lodging | $145.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,243.50 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $1,795.71 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $783.43 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $675.08 | 2020-2021 | |
| Glaxosmithkline, LLC. | $591.45 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $560.11 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $482.23 | 2021-2025 | Freestyle Libre 3, Penta |
| Corium, LLC | $460.18 | 2022-2025 | Azstarys |
| Stryker Corporation | $392.57 | 2024 | Insignia, Mako |
| Pfizer INC. | $388.07 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $337.82 | 2022 | |
| Merck Sharp & Dohme LLC | $319.45 | 2019-2024 | Capvaxive, Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $296.72 | 2021-2025 | |
| Amgen INC. | $282.86 | 2019 | |
| Dexcom, INC. | $275.56 | 2023-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.